期刊文献+

高血压左室肥厚与循环血胰岛素样生长因子-1和一氧化氮水平相关性的研究 被引量:6

Relationship between left ventricular hypertrophy induced by hypertension and the levels of insulin- like growth factor- 1 and nitric oxide
下载PDF
导出
摘要 目的:观察原发性高血压(EH)患者循环血胰岛素样生长因子-1(IGF-1)和一氧化氮(NO)水平的改变,探讨它们在高血压左心室肥厚(LVH)发生发展中的作用。方法:采用放射免疫分析法(RIA)和硝酸还原酶法检测50例EH患者犤EH组,其中LVH20例(LVH亚组),非LVH30例(非LVH亚组)犦和30名健康人血清IGF-1和NO水平,并对结果进行相关分析。结果:EH组血清IGF-1明显高于正常对照组(P<0.01),NO明显低于正常对照组(P<0.01);LVH亚组血清IGF-1明显高于非LVH亚组(P<0.01),NO显著低于非LVH亚组(P<0.01),且IGF-1与NO水平呈负相关(r=-0.435,P<0.05);左心室重量指数(LVMI)与IGF-1呈正相关(r=0.398,P<0.05),与NO呈负相关(r=-0.653,P<0.01)。LVH患者治疗后,血清IGF-1水平明显低于治疗前(P<0.05),NO水平明显高于治疗前(P<0.01)。结论:EH患者血清IGF-1水平明显升高,NO水平明显降低,合并LVH者更甚,IGF-1和NO两者失衡可能参与了EH及LVH形成的病理生理过程。 Objective To observe the changes of the levels of insulin-like growth factor-1 (IGF-1) and nitric oxide (NO) in the patients with essential hypertension (EH), and to explore their effects on the occurrence and development of left ventfieular hypertrophy (LVH). Methods 20 hypertensives with LVH(LVH group), 30 hypertensives without LVH(none LVH group), and 30 healthy volunteers(the control group) were included in the study. The serum IGF-1 and NO levels of these participants were detected by radioimmunoassay (RIA) and nitrate reductase test and the data were analysed. Results The serum IGF-1 levels in LVH and none LVH groups were significantly higher than that in the control group (P 〈 0. 01), whereas the serum NO levels in LVH and none LVH groups were lower ( P 〈 0. 01); The serum IGF-1 level in group was higher than that in none LVH group ( P 〈 0.01 ), while the serum NO level in LVH group was lower ( P 〈 0. 01 ). There was a negative correlation between IGF-1 and NO ( r = - 0. 435, P 〈 0. 05) . LVMI was positively correlated with IGF-1 ( r = 0. 398, P 〈 0.05) and negatively correlated with NO ( r = - 0. 653, P 〈 0.01 ). The serum IGF-1 levels in 17 normotensives with LVH after anti-hypertensive therapy were significantly lower than those before the treatment ( P 〈 0. 05), whereas the serum NO levels were higher ( P 〈 0.01 ). Conclusions The level of serum IGF-1 is markedly increased and the NO level decreased in the patients with EH, especially in those with EH and LVH. The imbalance between IGF-1 and NO is probably involved in the pathophysiological process of the development of EH and LVH.
出处 《实用医学杂志》 CAS 2006年第7期770-772,共3页 The Journal of Practical Medicine
基金 温州市科技局科研基金资助项目(Y2004A133)
关键词 高血压肥大 左心室 胰岛素样生长因子-1 一氧化氮 Hypertension Hypertrophy, left ventricular Insulin-like growth factor-1 Nitric oxide
  • 相关文献

参考文献13

  • 1TADDEI S, VIRDIS A, GHIADONI L, et al. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications [J]. Drugs, 2002, 62(2):265 -284.
  • 2朱志军.胰岛素样生长因子1的系统生物学特性及其在冠心病发病中之作用[J].心脏杂志,2002,14(5):433-434. 被引量:1
  • 3黄顺伟,高修仁,唐可京.原发性高血压患者循环中IGF-1水平与心肌肥厚的研究[J].中国病理生理杂志,2005,21(4):696-699. 被引量:10
  • 4HOLWERDA N J, FOGARI R, ANGELI P, et al. Valsartan, a new angiotensin Ⅱ antagonist for the treatment of essential hypertension:efficacy and safety compared with placebo and enalapril [J] . J Hypertens, 1996, 14(9): 1147-1151.
  • 5REN J, SAMSON W K, SOWERS J R, Insulin-like growth factor Ⅰ as a cardiac hormone: physiological and pathophysiological implications in heart disease [J]. J Mol Cell Cardiol, 1999, 31 (11 ) :2049 -2061.
  • 6潘芙蓉,谢克俭,王爱霞.原发性高血压患者血清胰岛素样生长因子-1水平的变化[J].温州医学院学报,2004,34(3):214-215. 被引量:1
  • 7VECCHIONE C, COLELLA S, FRATYA L, et al. Impaired insulin-like growth factor Ⅰ vasorelaxant effects in hypertension [J].Hypertension, 2001, 37 (6) : 1480 - 1485.
  • 8VERDECCHIA P, REBOLDI G, SCHILLACI G, et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension [J] .Circulation, 1999,100(17) : 1802 - 1807.
  • 9NATHAN C. Nitric oxide as a secretory product of mammalian cells[J]. FASEB J, 1992, 6(12):3051-3064.
  • 10ISENOVIC E, MUNIYAPPA R, MILIVOJEVIC N, et al. Role of P13-kinase in isoproterenol and IGF-1 induced ecNOS activity [J] .Biochem Biophys Res Commun, 2001,285 (4) : 954 - 958.

二级参考文献34

  • 1Ren J, Samson WK,Sowers JR. In sulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease[ J]. J Mol Cell Cardiol, 1999,31 ( 11 ): 2649 - 2061.
  • 2Tofe I, Bonaa KH,Jenssen T. Insulin resistance in hypertension is associated with body fat rather than blood pressure [ J]. Hypertension,1998,32(1): 115 - 122.
  • 3Ebensperger R, Acevedo E, Melendez J, et al. Selective increase in cardliac IGF-1 in a rat model of ventricular hypertrophy[ J]. Bioehem Biophys Res Commun, 1998,243 ( 1 ): 20 - 24.
  • 4Leri A, Liu Y, Claudio PP, et al. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis[J]. Am J Pathol,1999,154(2) :567 - 580.
  • 5Hasdai D, Nielsen MF, Rizza RA, et al. Attenuated in vitro coronary arteriolar vasorelaxation to insulin-like growth factor I in experimental hypereholesterolemia[ J]. Hypertension, 1999,34( 1 ): 89 - 95.
  • 6Jalil JE, Ebensperger R, Me le ndez J, et al. Effects of antihypertensive treatment on cardiac IGF-1 during prevention of ventricular hypertrophy in the rt[J]. Life Sci,1999,64(18) :1603 - 1612.
  • 7Rosen CJ, Pollak M. Circulating IGf-1: New perspectives for a new century[J]. TEM, 1999, 10(4): 136-141.
  • 8Twigg SM, Baxter RC. IGF-1 binding protein 5 forms an alternative ternary complex with IGFs and the acid lable subunit [J]. J Biol Chem, 1998, 273(11): 6074-6079.
  • 9Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparion to necropsy findings[J]. AmJ Cardiol, 1986, 57(6): 450-458.
  • 10Iso H, Kiyama M, Dio M, et al. Left ventricular mass and subsequent blood pressure changes among middle-aged men in rural and urban Japanense population [ J ]. Circulation,1994, 89(4): 1717-1724.

共引文献9

同被引文献45

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部